265
Participants
Start Date
June 30, 2008
Primary Completion Date
October 31, 2008
Study Completion Date
October 31, 2008
PEP005 Topical Gel
0.005%, two days treatment
PEP005 Topical Gel
0.01%, two days treatment
PEP005 Topical Gel
0.015%, two days treatment
Vehicle gel
two days treatment
PEP005 Topical Gel
0.005%, three days treatment
PEP005 Topical Gel
0.01%, three days treatment
PEP005 Topical Gel
0.015%, three days treatment
Vehicle gel
three days treatment
Southderm Pty Ltd, Kogarah
Siller Medical, Brisbane
The Skin Centre, Benowa
Philadelphia Institute of Dermatology, Philadelphia
Spencer Derm and Skin Surgery Center, St. Petersburg
Dermatology Research Associates, Nashville
South Bend Clinic, South Bend
Minnesota Clinical Study Center, Fridley
Altman Dermatology Associates, Arlington Heights
Christie Clinic, Champaign
Koppel Dermatology, Los Angeles
Burke Pharmaceutical Research, Hot Springs
Dermatology Research of Arkansas, Little Rock
Dermatology Associates of Tyler, Tyler
Suzanne Bruce and Associates, The Center for Skin Research, Houston
Dermatology Clinical Research Center of San Antonio, San Antonio
Progressive Clinical Research, San Antonio
DermResearch, Inc. 8140 N. MoPac, Bldg. 3, Suite 120,, Austin
Northwest Clinical Trial, Boise
Academic Dermatology Associates, Albuquerque
Dermatology Research Associates, Los Angeles
Dermatology Specialists Inc, Vista
Skin Surgery Medical Group Inc, San Diego
Integrated Research Group Inc, Riverside
470 Castro St Suite 202-204, San Francisco
Solano Clinical Research, Vallejo
Oregon Medical Research Center, Portland
TKL Research, Inc., Paramus
Lead Sponsor
Peplin
INDUSTRY